Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042499Phase 4Recruiting
Phase 4, randomised, open-label trial of levofloxacin in endophthalmitis (3 arms), sponsored by Beijing Chaoyang Hospital, Capital Medical University. Primary endpoint: Aqueous humor level of levofloxacin. Started Feb 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042499.